<?xml version="1.0" encoding="utf-8" ?>


<rss version="2.0">
    <channel>
        <title><![CDATA[Oncology]]></title>
        <link><![CDATA[http://www.getinsidehealth.com/en/Oncology/]]></link>
        <language><![CDATA[en-GB]]></language>
        <pubDate><![CDATA[10/11/2010 5:54:00 PM]]></pubDate>
    
    
            <item>
                <title><![CDATA[CT features of PTCL of the GI tract]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/May/CT-features-of-PTCL-of-the-GI-tract/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20May/052012_26_RSSembed.jpg"/><br /><p>Primary gastrointestinal (GI) lymphoma is very rare, constituting 1–4% of all malignancies that affect the GI tract. Stomach is the most common site to be involved (>50%) in GI lymphoma followed by small bowel (20–50%) and colon (4–6%). The majority of primary GI lymphomas are non‐Hodgkin... </p><br/>Article by: Australasian Radiology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 17 May 2012 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Review: MRI evaluation of bladder cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/May/Review-MRI-evaluation-of-bladder-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20May/052012_25_RSSembed.jpg"/><br /><p>An estimated 70 530 new cases of bladder cancer were diagnosed in the USA in 2010, resulting in 14 680 deaths . Initially, 70% of patients present with non‐muscle invasive bladder cancer (NMIBC), and 30% with muscle‐invasive bladder cancer (MIBC) . Despite transurethral resection... </p><br/>Article by: BJU International 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 15 May 2012 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[MRI evaluation of colorectal cancer recurrence]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/May/MRI-evaluation-of-colorectal-cancer-recurrence/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20May/052012_24_RSSembed.jpg"/><br /><p>Despite the widespread use of total mesorectal excision and neoadjuvant therapy, between 2.6 % and 32 % of patients with rectal
            cancer will develop pelvic recurrence after initial curative surgery . In addition, local recurrence (LR) is seen in up to 20 % of patients who had... </p><br/>Article by: Abdominal Imaging 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 14 May 2012 16:06:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Combined DW- and CE-MRI predict breast chemo response]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/May/Combined-DW--and-CE-MRI-predict-breast-chemo-response/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20May/052012_22_RSSembed.jpg"/><br />Neoadjuvant chemotherapy (NAC) has been established as the standard-of-care treatment for locally advanced inoperable breast
               cancer, but it is increasingly being used for patients with operable cancer [, ]. It has been established that when patients can achieve pathologic complete response... <br/>Article by: Breast Cancer Research and Treatment 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 14 May 2012 16:06:35 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Imaging renal vein leiomyosarcoma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/May/Imaging-renal-vein-leiomyosarcoma/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20May/052012_23_RSSembed.jpg"/><br />Leiomyosarcoma, or malignant smooth muscle tumor, is a common histology among retroperitoneal sarcomas. However, most of these
            are intramuscular in origin. Only about 5% of leiomyosarcomas arise directly from large blood vessels ; the vast majority of these from the inferior vena cava (IVC)... <br/>Article by: Abdominal Imaging 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 14 May 2012 16:06:35 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[FDG-PET/CT and lung cancer assessment]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/May/FDG-PETCT-and-lung-cancer-assessment/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20May/052012_27_RSSembed.jpg"/><br />Radiotherapy plays a major role in the treatment of non&#8208;small cell lung cancer (NSCLC). Curative radiotherapy requires delivery of high doses of radiation to the lung cancer while limiting radiation dose to surrounding normal structures. To maximise the therapeutic ratio, accurate delineation of... <br/>Article by: Australasian Radiology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 14 May 2012 16:06:36 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[US elastography shows promise in thyroid cancer diagnosis]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/May/US-elastography-shows-promise-in-thyroid-cancer-diagnosis/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20May/052012_31_RSSembed.jpg"/><br />Ultrasonography is considered useful to distinguish between solid and cystic thyroid nodules and to stratify a nodule&rsquo;s risk of cancer as low, medium, or high. Ultrasound (US) elastography has been applied to study the hardness/elasticity of nodules to differentiate malignant from benign lesions.... <br/>Article by: Endocrine Research 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 14 May 2012 16:06:36 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[MRI detection of breast cancer recurrence]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/May/MRI-detection-of-breast-cancer-recurrence/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20May/052012_28_RSSembed.jpg"/><br />Use of magnetic resonance imaging (MRI) for investigation of breast disease is increasing. In certain scenarios MRI has been
            confirmed as superior to other diagnostic imaging modalities used in breast disease, mainly for screening in high risk (&gt;20-30&nbsp;%
            risk) young women.... <br/>Article by: Annals of surgical oncology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 14 May 2012 16:06:36 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[FDG-PET role in rectal cancer evaluation?]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/May/FDG-PET-role-in-rectal-cancer-evaluation/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20April/042012_24_RSSembed.jpg"/><br />FDG-PET may be considered in patients with colorectal cancer who have stage IV disease to assess the resectability of known metastasis and to identify additional sites of metastatic disease that may preclude operative management. In addition, FDG-PET has been used in patients with colorectal cancer concerning... ]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 14 May 2012 16:06:36 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[PET-CT, dose escalation, and QoL in prostate cancer patients]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Apr/PET-CT-dose-escalation-and-QoL-in-prostate-cancer-patients/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20April/042012_29_RSSembed.jpg"/><br /><p>Increasing doses for prostate cancer have been shown to be associated with improved biochemical control rates in several prospective randomized studies  . However, rectal toxicity has also increased significantly. Rectal toxicity is known to be the dose-limiting toxicity in prostate cancer radiotherapy... </p><br/>Article by: Radiation Oncology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 08 Apr 2012 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Cochrane review: managing follicular lymphoma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Apr/Cochrane-review-managing-follicular-lymphoma/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20April/042012_31_RSSembed.jpg"/><br /><p>There might be some heterogeneity between trials. The risk for the low risk population (of patients with follicular lymphoma) was taken from the trial with the highest rates of survival at 5 years (GELF94 trial). The high risk rate is approximately the risk in the CUP-trial, for relapsed patients. No... </p><br/>Article by: The Cochrane Database of Systematic Reviews]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 05 Apr 2012 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[CT planning in head and neck cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Apr/CT-planning-in-head-and-neck-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20April/042012_30_RSSembed.jpg"/><br /><p>The use of radiotherapy (RT) in the treatment of head and neck (H&N) cancer has significantly improved over the last decade.
               Two-dimensional, conventional large fields have been extensively replaced by more sophisticated techniques, such as 3D conformal
               radiotherapy... </p><br/>Article by: International Journal of Clinical Oncology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 03 Apr 2012 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Meta-analysis assesses elastography accuracy in breast disease]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Apr/Meta-analysis-assesses-elastography-accuracy-in-breast-disease/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20April/042012_26_RSSembed.jpg"/><br /><p>Breast physical examination, mammography and B-mode ultrasonography (USB) are the triad commonly used for characterization
               of breast masses and assessment of their risk for malignancy. The diagnostic confirmation of suspicious lesions is established
               by histopathological... </p><br/>Article by: Breast Cancer Research and Treatment 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 01 Apr 2012 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Characterizing gastric lesions]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Apr/Characterizing-gastric-lesions/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20April/042012_27_RSSembed.jpg"/><br /><p>Gastric adenomas are benign epithelial neoplastic tumors with a glandular organization that are characterized by localized proliferation of adenomatous epithelium with tubular and/or papillary structures.   Non‐invasive carcinomas occasionally coexist within gastric adenomas and demonstrate... </p><br/>Article by: Digestive Endoscopy 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 01 Apr 2012 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Combined MRI techniques preoperatively predict peritoneal cancer index]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Apr/Combined-MRI-techniques-preoperatively-predict-peritoneal-cancer-index/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Mar/032012_24_RSSembed.jpg"/><br /><p>The peritoneal cancer index (PCI) provides a measurement of the volume and extent of peritoneal tumor found at laparotomy.
            The PCI score combines the distribution of peritoneal tumor at 13 abdominal and pelvic regions with the tumor size. The PCI is the most widely validated and precise quantitative... </p><br/>Article by: Annals of surgical oncology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 16 Apr 2012 08:52:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[New techniques allow accurate evaluation of small colorectal lesions]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Apr/New-techniques-allow-accurate-evaluation-of-small-colorectal-lesions/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Mar/032012_28_RSSembed.jpg"/><br /><p>Colorectal cancer has been recognized as the second most common cause of cancer-related death in the United States, and it is known to progress through stages of low-grade dysplasia (both polypoid and flat) to high grade and ultimately to invasive carcinoma . Small, distal hyperplastic polyps traditionally... </p><br/>Article by: The American Journal of Gastroenterology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 10 Apr 2012 09:16:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Prostate cancer: developments in radiation therapy]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Mar/Prostate-cancer-developments-in-radiation-therapy/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13893/20120305_a2_webAppMobileRSS.jpg"/><br />A round-up and review of some recently published research on radiation therapy for prostate cancer.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sat, 31 Mar 2012 18:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Review: diagnostic imaging and radiation exposure]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Mar/Review-diagnostic-imaging-and-radiation-exposure/]]></link>
                <description>
                <![CDATA[Since the discoveries of x‐rays, radium, and radioactivity from uranium salts during the late 19th century, remarkable experimental, clinical, and technological developments in radiologic imaging have continued to transform medicine, as summarized in Table ., A few years after x‐rays were...<br/>Article by: CA: A Cancer Journal for Clinicians 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 01 Mar 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Review: DCE-MRI in antivascular therapy trials]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Mar/Review-DCE-MRI-in-antivascular-therapy-trials/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Mar/032012_23_RSSembed.jpg"/><br />Dynamic contrast-enhanced (DCE)-MRI allows noninvasive quantification of microvascular structure and function. Although many early-phase clinical trials of antivascular agents have incorporated DCE-MRI end points in their protocols, the role of this imaging technique in drug development remains controversial;...<br/>Article by: Nature Reviews Clinical Oncology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 01 Mar 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[The future of palliative thoracic radiotherapy]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Mar/The-future-of-palliative-thoracic-radiotherapy/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Mar/032012_30_RSSembed.jpg"/><br />Palliative thoracic radiotherapy has been a mainstay of radiation oncology practice for decades. The main goal for this type of therapy has been in the efficient and effective management of symptoms related to tumor effects on various anatomic structures located in or around the thorax. These include...<br/>Article by: Current Opinion in Supportive and Palliative Care 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 01 Mar 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Evaluating tumor cellularity predicts hypopharyngeal cancer prognosis]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/Evaluating-tumor-cellularity-predicts-hypopharyngeal-cancer-prognosis/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20February/022012_24_RSSembed.jpg"/><br /><h3>Abstract&nbsp;&nbsp;</h3>
<p>The aim of this study is to clarify the prognostic value of the pathological overall tumor cellularity after neoadjuvant chemotherapy for locally advanced hypopharyngeal cancer.</p><br/>Article by: European Archives of Oto-Rhino-Laryngology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 22 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Brachytherapy role in treating recurrent prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/Brachytherapy-role-in-treating-recurrent-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20February/022012_27_RSSembed.jpg"/><br />The two established therapies for localized prostate cancer are radiation therapy and radical prostatectomy . Radiation therapy has proved successful for patients in different risk groups and reported 5‐year prostate‐specific antigen (PSA) relapse‐free rates for low‐risk patients...<br/>Article by: BJU International 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 15 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Ultrasound versus PET-CT for esophageal cancer staging]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/Ultrasound-versus-PET-CT-for-esophageal-cancer-staging/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20February/022012_28_RSSembed.jpg"/><br />Esophageal cancer is the eighth most common cancer worldwide and the third most frequent cancer affecting the digestive tract.&nbsp;&nbsp; The incidence rate of esophageal adenocarcinoma has increased rapidly in the USA and Western Europe, especially among white males. In addition, the incidence of esophageal...<br/>Article by: Diseases of the Esophagus 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 15 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Late recurrence of non-small cell lung cancer after SBRT]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/Late-recurrence-of-non-small-cell-lung-cancer-after-SBRT/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20February/022012_21_RSSembed.jpg"/><br />Stereotactic body radiation therapy (SBRT) is a recently developed and innovative radiotherapeutic technique that has been applied primarily to the lungs. SBRT is one of the more important treatment options for early non-small cell lung cancer (NSCLC), especially in inoperable or elderly patients.esophageal...<br/>Article by: Journal of Thoracic Oncology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 15 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[EGFR, TB, and lung adenocarcinoma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/EGFR-TB-and-lung-adenocarcinoma/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20February/022012_22_RSSembed.jpg"/><br />Lung cancer is the leading cause of cancer death throughout the world. Approximately 12.4% of all newly diagnosed cancer cases are lung cancers, and lung cancer accounts for 29% of all cancer deaths. Tuberculosis (TB) is one of the major causes of death among infectious diseases and remains a global...<br/>Article by: Journal of Thoracic Oncology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 08 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Colorectal cancer incidence after negative CT screen]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/Colorectal-cancer-incidence-after-negative-CT-screen/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20February/022012_29_RSSembed.jpg"/><br />Computed tomography colonography (CTC) is a less invasive alternative method to colonoscopy. Several multicentre trials have validated performance in large polyps and masses, leading to inclusion in the American Cancer Society colorectal cancer (CRC) screening guidelines . CTC-based screening...<br/>Article by: European Radiology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 08 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Audio interview: the need for breast screening]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/Audio-interview-the-need-for-breast-screening/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13835/20120206_obg01_150.jpg"/><br />A leading specialist discusses the legitimacy of recent challenges to the rationale behind breast screening programs.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 29 Feb 2012 15:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Review: strategies for radionuclide based imaging]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/Review-strategies-for-radionuclide-based-imaging/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13839/022012_25_webAppMobile%26RSS.jpg"/><br />High expression of epidermal growth factor receptor (EGFR)-family receptors, especially EGFR, HER2, and HER3, makes them interesting for targeted radionuclide-based imaging and therapy of disseminated cancer.<br/>Article by: Tumor Biology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 02 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Breast imaging and axillary nodal involvement]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/Breast-imaging-and-axillary-nodal-involvement/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20February/022012_26_RSSembed.jpg"/><br />Axillary lymph node status remains among the most important breast cancer prognostic factors and is essential for establishing treatment decisions. The standard for determining axillary involvement is via a sentinel lymph node biopsy (SLNB). SLNB uses radiotracer or blue dye to...<br/>Article by: Annals of surgical oncology 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 02 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Improving cervical cancer risk stratification]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/Improving-cervical-cancer-risk-stratification/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20February/022012_30_RSSembed.jpg"/><br />The Pap test, originally developed in the 1960s, is an effective method for screening women at risk for cervical cancer. The primary goals are to identify neoplastic and pre-neoplastic epithelial cells, to stratify women for the risk of cervical cancer, and to isolate...<br/>Article by: Annals of biomedical engineering 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 02 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[HIFU for prostate cancer: 7-years' experience]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Feb/HIFU-for-prostate-cancer-7-years-experience/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20February/022012_23_RSSembed.jpg"/><br />Prostate cancer is the most common cancer and the second leading cause of cancer death in men in the United States and Europe . The choice of treatment for prostate cancer depends on several factors such as age, life expectancy, cancer stage, comorbidities, and patient preference. Among the many treatment...<br/>Article by: The Prostate 2012]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 02 Feb 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Psychosocial factors in breast cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Jan/Psychosocial-factors-in-breast-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Jan/012012_21_RSSembed.jpg"/><br />Breast cancer is the most common cancer in women worldwide regardless of the country's level of development . In Korean women, breast cancer was the most common cancer after gastric cancer in 2001. However, in 2002, it became the most common cancer in Korean women and comprised 16.8% of...<br/>Article by: Supportive Care in Cancer 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 17 Jan 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[PWI distinguishes recurrent glioma and radiation injury]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Jan/PWI-distinguishes-recurrent-glioma-and-radiation-injury/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Jan/012012_22_RSSembed.jpg"/><br />Distinction between postoperative recurrent glioma and radiation injury (RI) remains a tough diagnostic problem for a long time because, in most cases, the two entities have mimic clinical manifestations and conventional imaging findings.&nbsp;&nbsp; To obtain certain diagnosis, the surgical biopsy,...<br/>Article by: Australasian Radiology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 10 Jan 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Dose evaluation of radiotherapy techniques]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Jan/Dose-evaluation-of-radiotherapy-techniques/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Jan/012012_23_RSSembed.jpg"/><br />The use of conservative surgery combined with whole‐breast irradiation (WBI) has been established as a valid alternative to mastectomy for the management of early‐stage breast cancer. Recently updated 20‐year results of breast‐conservation therapy trials have shown comparable...<br/>Article by: Australasian Radiology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 03 Jan 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Advances in renal cell cancer imaging]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Jan/Advances-in-renal-cell-cancer-imaging/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Jan/012012_30_RSSembed.jpg"/><br />Renal cell carcinoma (RCC) is the 13th most common cancer worldwide and accounts for 4% of all adult malignancies. Herein the state of the art and recent advances in cross-sectional radiological imaging applied to RCC are reviewed, including ultrasonography, computed tomography, magnetic resonance imaging,...<br/>Article by: Urologia Internationalis 2010]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 03 Jan 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Review: radionuclide imaging of prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Jan/Review-radionuclide-imaging-of-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Jan/012012_27_RSSembed.jpg"/><br />Prostate cancer remains the most common malignancy in men in Europe, with an incidence of 382,000 cases and a mortality rate of 89,000 in 2008 . In early stages of the disease, neoplastically transformed prostate cells are confined to the prostate gland. In later stages malignant cells metastasize to...<br/>Article by: The Prostate 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 03 Jan 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RFA in bilateral renal cell cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Jan/RFA-in-bilateral-renal-cell-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%202012/GNM%20Jan/012012_26_RSSembed.jpg"/><br />The incidence of bilateral RCC has been reported to vary from 1.8% to 11.0%. Surgery is the method of choice for treating bilateral sporadic RCC, as it has a comparable prognosis to that for unilateral sporadic RCC. However, bilateral synchronous RCC poses a surgical challenge in balancing oncological...<br/>Article by: International Journal of Urology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 03 Jan 2012 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Elastography and breast disease]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Jan/Elastography-and-breast-disease/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13741/150_20110104_a2.jpg"/><br />New research findings are showing how elastography could help improve diagnosis in patients with suspected breast cancer.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 31 Jan 2012 15:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Echo contribution to identifying abnormalities in cancer patients]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Jan/Echo-contribution-to-identifying-abnormalities-in-cancer-patients/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20December/122011_25_RSSembed.jpg"/><br />The prevalence of cardiovascular (CV) disease in the cancer population may be higher than in the general population because of shared risk factors, age, and the impact of cancer therapy on CV function. In addition, as many patients survive with cancer for years, they are faced with treatment‐related...<br/>Article by: Echocardiography 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 10 Jan 2012 14:25:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[HIFU as salvage therapy in localized prostate cancer recurrence]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Dec/HIFU-as-salvage-therapy-in-localized-prostate-cancer-recurrence/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20December/122011_27_RSSembed.jpg"/><br />Men who have external beam radiation therapy (EBRT) for clinically localized prostate cancer have a 20% to 63% chance of experiencing biochemical failure. Salvage prostatectomy, cryosurgery, brachytherapy, and high-intensity focused ultrasound (HIFU) have been applied for localized recurrence after EBRT,...<br/>Article by: Cancer 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 15 Dec 2011 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[PET-CT role in managing Merkel cell carcinoma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2012/Jan/PET-CT-role-in-managing-Merkel-cell-carcinoma/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20December/122011_21_RSSembed.jpg"/><br />Merkel cell carcinoma (MCC) is a rare but potentially aggressive cutaneous malignancy of neuroendocrine origin where accurate staging greatly assists with prognosis and relevant management especially regarding treatment. However, optimal staging methods in MCC patients remain unclear to date. Sentinel...<br/>Article by: Journal of the European Academy of Dermatology and Venereology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 10 Jan 2012 14:25:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Insights from the National Lung Screening Trial (UPDATED with new trial data Nov 2011)]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Dec/Insights-from-the-National-Lung-Screening-Trial-UPDATED-with-new-trial-data-Nov-2011/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13593/062011_22_150.jpg"/><br />Should low-dose helical CT now be the method of choice for lung cancer screening? In November 2010 the USA’s National Cancer Institute (NCI) released early findings from the National Lung Screening Trial (NLST) showing that screening with low-dose helical CT was associated with a significant mortality benefit compared with chest X-ray screening, in older current and former heavy smokers. Overall, there were 20% fewer lung cancer deaths in the population screened using CT than in the population screened using X-ray.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sat, 31 Dec 2011 05:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Consensus report: surveillance and focal therapy in prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Dec/Consensus-report-surveillance-and-focal-therapy-in-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20December/122011_28_RSSembed.jpg"/><br />The management of men with prostate cancer is set to become one of the most challenging public health issues in coming years if the current pathway of care is left unchecked. This article presents the findings of a transatlantic consensus group, which was convened in May 2010 to deliberate on the problems...<br/>Article by: BJU International 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 30 Dec 2011 09:43:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Study compares imaging techniques for localizing prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Dec/Study-compares-imaging-techniques-for-localizing-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20Nov/112011_24_RSSembed.jpg"/><br />Magnetic resonance imaging (MRI) and MR spectroscopic imaging (MRSI) have been gaining acceptance as tools in the evaluation of prostate cancer. We compared the accuracy of transrectal ultrasound (TRUS)-guided biopsy and dynamic contrast-enhanced MRI combined with three-dimensional (3D) MRSI in locating...<br/>Article by: Urologia Internationalis 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 22 Dec 2011 12:28:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Update: endoscopic management of gastric cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Nov/Update-endoscopic-management-of-gastric-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20Nov/112011_28_RSSembed.jpg"/><br />Gastric cancer is the fourth most common malignancy and the second most common cause of cancer-related death in the world [1]. Although most common in Asian populations, in the United States, the 2007 age adjusted incidence of gastric cancer was 7.8 per 100 000. Although this represents a decrease over...<br/>Article by: Current Opinion in Gastroenterology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 09 Nov 2011 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[PET and brain tumors: a guide for referring physicians]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Nov/PET-and-brain-tumors-a-guide-for-referring-physicians/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20Nov/112011_26_RSSembed.jpg"/><br />PET allows noninvasive, quantitative studies of various biologic processes in tumor tissue [1,2•]. In brain cancer, however, the contribution of this technique into the clinical practice remains relatively modest and many referring physicians still regard PET as a decorative more than a decision-making...<br/>Article by: Current Opinion in Oncology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 04 Nov 2011 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Interview: advances in ablation of renal tumors]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Nov/Interview-advances-in-ablation-of-renal-tumors/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13566/150.jpg"/><br />How ablation techniques are challenging surgery in terms of successful long-term outcomes in the treatment of renal tumors.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 01 Nov 2011 20:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Fluorescence imaging for evaluating colonic neoplasms]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Dec/Fluorescence-imaging-for-evaluating-colonic-neoplasms/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20October/102011_29_RSSembed.jpg"/><br />Colorectal cancers arise from the progressive accumulation of genetic and epigenetic alterations that lead to the transformation of normal colonic epithelium to colon adenocarcinoma. In this sequential process, normal epithelia are believed to initially turn into adenomas...<br/>Article by: International Journal of Colorectal Disease 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 01 Dec 2011 13:56:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Real-time elastography versus conventional ultrasound in prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Dec/Real-time-elastography-versus-conventional-ultrasound-in-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20Nov/112011_30_RSSembed.jpg"/><br />Accurate staging is necessary to optimize the counselling and treatment of patients with biopsy‐proven prostate cancer (PCa). Nomograms are commonly used to preoperatively predict pathological tumour characteristics [1]. Nomogram risk calculation is based upon different preoperative parameters,...<br/>Article by: BJU International 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 01 Dec 2011 13:56:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Urethral stricture after HIFU relates to survival]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/Urethral-stricture-after-HIFU-relates-to-survival/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20October/102011_24_RSSembed.jpg"/><br />Purpose To assess the association between the development of a urethral stricture (US) and disease-free survival for patients with localized prostate cancer treated with high-intensity focused ultrasound (HIFU). Patients and Methods Patients with clinical stage T1-T2N0M0 prostate cancer were eligible...<br/>Article by: Urologia Internationalis 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 21 Oct 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Review: 18-FDG-PET in multiple myeloma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/Review-18-FDG-PET-in-multiple-myeloma/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20October/102011_27_RSSembed.jpg"/><br />Bone disease is common in patients with multiple myeloma, developing in 90% of patients during the course of the disease. Due to the resulting pain, spinal cord compression and hypercalcemia, this disease has a major impact on quality of life. Accurate investigation of bone disease in multiple myeloma...<br/>Article by: Cancer 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 14 Oct 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[MRI, liver cancer, and progenitor cell markers]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/MRI-liver-cancer-and-progenitor-cell-markers/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20October/102011_23_RSSembed.jpg"/><br />Hepatic progenitor cells (HPCs) are immature epithelial cells with an ovoid nucleus that are located in the terminal branches of the biliary tree in the human liver and can give rise to hepatocellular carcinoma (HCC) 1&nbsp;. Several studies have shown that some HCCs express one or more progenitor cell...<br/>Article by: Liver 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 14 Oct 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Imaging infantile subglottic hemangioma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/Imaging-infantile-subglottic-hemangioma/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20October/102011_22_RSSembed.jpg"/><br />Infantile haemangiomas are benign endothelial cell neoplasms that are not present at birth but generally appear after a few weeks. They grow rapidly throughout the first year of life, then slowly involute. Haemangiomas are easily diagnosed at US as well-defined mostly hypoechoic...<br/>Article by: Pediatric Radiology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 12 Oct 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Image-guided ablation is gaining on surgery for resectable liver tumours]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/Image-guided-ablation-is-gaining-on-surgery-for-resectable-liver-tumours/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13504/150.jpg"/><br />Image-guided ablation has many advantages over surgical resection in the treatment of liver malignancies, whether the tumours are primary or metastatic. Minimally invasive ablation techniques, which include energy delivered by radiofrequency or microwave or destruction of tissue by freezing, typically allow fast recovery and a relatively low risk of complications. A debate about whether ablation will eventually replace surgery in the treatment of liver tumours failed to materialize when both sides agreed that both options are important.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sat, 01 Oct 2011 20:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[1.5T MRI in endometrial cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/15T-MRI-in-endometrial-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20October/102011_26_RSSembed.jpg"/><br />Endometrial carcinoma is the most common gynecologic malignancy in the United States, and its frequency is increasing in China. It usually occurs in postmenopausal women, presenting with atypical genital bleeding. The histological tumor grade and depth of myometrial invasion...<br/>Article by: Archives of Gynecology and Obstetrics 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 30 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Comparing mammographically dense and non-dense breast tissue]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/Comparing-mammographically-dense-and-non-dense-breast-tissue/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20October/102011_29_RSSembed.jpg"/><br />Mammographic density is a strong and consistent risk factor for breast cancer [1, 2]. Women with dense tissue occupying over 60-75% of the breast are at 3-6 times greater risk of breast cancer than women with little or no density [3, 4]. However, what breast density represents at the tissue...<br/>Article by: Breast Cancer Research and Treatment 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 30 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Ultrasound- versus palpation-guided lumpectomy in breast cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/Ultrasound--versus-palpation-guided-lumpectomy-in-breast-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20October/102011_30_RSSembed.jpg"/><br />Breast conserving surgery (BCS) with lumpectomy and adjuvant radiation has become the treatment of choice for most early-stage breast cancers. The main goal of BCS is to remove the cancer with adequate tumor-free margins, thus reducing local recurrence, but a good cosmetic outcome...<br/>Article by: Annals of surgical oncology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 30 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Advances in diagnosing and treating small bowel tumors]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/Advances-in-diagnosing-and-treating-small-bowel-tumors/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20October/102011_21_RSSembed.jpg"/><br />The past decade marked a turning point in the assessment and management of diseases that affect the small bowel [1]. New endoscopic devices and techniques, such as capsule endoscopy (CE), double (DBE)- and single (SBE)-balloon enteroscopy, and spiral enteroscopy have been developed [2-5]....<br/>Article by: Surgical Endoscopy 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 30 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Does dual-timepoint FDG-PET/CT improve malignancy evaluation?]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Does-dual-timepoint-FDG-PETCT-improve-malignancy-evaluation/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_21_RSSembed.jpg"/><br /><p>Enhanced glycolysis is a common characteristic of many malignancies1 and has been studied in animals and humans with PET using fluorine‐18 (18F)‐fluoro‐deoxyglucose (18F‐FDG‐PET). As a glucose analogue, FDG travels via the blood stream, is transported into cells via specific... </p><br/>Article by: Australasian Radiology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 29 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Tomotherapy - 2-year study results published]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Tomotherapy---2-year-study-results-published/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_23_RSSembed.jpg"/><br /><p>The pooled 2-year clinical experience using three tomotherapy units installed in France in 2007 is presented. Treatment indications and protocols were devised for each disease site and were the result of a consensus. A total of 642 patients were treated for central nervous system, head and neck, thoracic,... </p><br/>Article by: Cancer Investigation 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 28 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Cervical cancer imaging reviewed]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Cervical-cancer-imaging-reviewed/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_28_RSSembed.jpg"/><br /><p>Imaging cervical cancer is largely restricted to morphological datasets with computerized tomography (CT) and magnetic resonance imaging (MRI). The 2010 guidelines from the European Society of Urogenital Radiologists currently recommend T2-weighted MRI for cervical cancer staging and follow-up with images... </p><br/>Article by: Current Opinion in Oncology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 27 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Minimally invasive ablation called new standard for small renal cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Oct/Minimally-invasive-ablation-called-new-standard-for-small-renal-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13484/150.jpg"/><br />Relative to nephron-sparing surgery for small renal tumours, either by open or laparoscopic technique, radiofrequency ablation (RFA) or cryoablation requires less recovery time, is less expensive to perform, and may reduce the risk of complications. However, it is not yet clear that long-term outcome is as good with ablation. This was the focus of a debate between a surgeon and an interventional radiologist. In a debate, a surgeon maintained that resection remains the first-line therapy for small renal cancers, but an interventional radiologist suggested that ablation is now a better alternative.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 31 Oct 2011 20:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Pre-op imaging for gastric cancer staging evaluated]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Pre-op-imaging-for-gastric-cancer-staging-evaluated/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_24_RSSembed.jpg"/><br /><p>Currently, resection is the only curative option available for patients with gastric cancer [1-4]. Accurate assessment of local tumor depth invasion (T), regional lymph node invasion (N), and distant metastases (M) is
               crucial to appropriate surgical and treatment planning [1, 2, 5]. Understaging... </p><br/>Article by: Gastric Cancer 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 22 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Advances in bladder cancer imaging reviewed]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Advances-in-bladder-cancer-imaging-reviewed/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_30_RSSembed.jpg"/><br /><p>Purpose of review  To present the recent advances in imaging for diagnosis, staging, and follow-up of bladder cancer.Recent findings  The use of multidetector 64-slice computed tomography (CT) and diffusion-weighted imaging has enabled higher-resolution imaging of bladder cancer on CT and MRI, respectively,... </p><br/>Article by: Current Opinion in Urology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 21 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Study investigates CETRUS role in prostate disease]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Study-investigates-CETRUS-role-in-prostate-disease/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_29_RSSembed.jpg"/><br />To investigate the value of contrast-enhanced transrectal ultrasound (CETRUS) in predicting the nature of prostate diseases and prostate cancer Gleason score. Methods 106 patients suspected of prostate cancer were evaluated with CETRUS followed by systematic biopsy. Prostate blood flow of CETRUS was...<br/>Article by: Urologia Internationalis 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 19 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Low-dose CT screening for lung cancer "promising"]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Low-dose-CT-screening-for-lung-cancer-promising/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_25_RSSembed.jpg"/><br />Lung cancer remains a leading cause of death in Europe and the UK [1] and in recent years, low dose computed tomography (LDCT) has been proposed as an effective screening tool [2]. Early studies demonstrated the ability of LDCT to detect early stage cancers, but definitive conclusions have been lacking ...<br/>Article by: European Radiology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 15 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[18-F-FCH tracer shows promise in prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/18-F-FCH-tracer-shows-promise-in-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_22_RSSembed.jpg"/><br />Prostate cancer (PCa) is a major cancer problem among men.1 The availability of PSA as a serum prostate biomarker coupled with a growing and aging population has resulted in a dramatic increase in the incidence of PCa.2 In contemporary patients, PSA is most highly correlated with overall prostate volume,...<br/>Article by: Prostate Cancer and Prostatic Diseases 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 14 Sep 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Spotlight on cancer screening]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Spotlight-on-cancer-screening/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13410/150.jpg"/><br /><p>What do the latest data show about the effectiveness of screening for breast and lung cancers?</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 30 Sep 2011 20:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Review: surveillance mammography assessed]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Review-surveillance-mammography-assessed/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_26_RSSembed.jpg"/><br />In women previously treated for breast cancer, surveillance mammography is useful for early detection of tumour recurrence, or for confirming the absence of recurrent cancer, and for the early detection of contralateral cancers. Although published figures vary, it has been...<br/>Article by: European Radiology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 31 Aug 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Which strategy for low-risk prostate cancer?]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Sep/Which-strategy-for-low-risk-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20september/092011_27_RSSembed.jpg"/><br />Widespread prostate-specific antigen (PSA) –based screening and aggressive treatment of prostate cancer have reduced mortality rates substantially, but both remain controversial in large part because of high rates of overdiagnosis and overtreatment of otherwise...<br/>Article by: JCO 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 31 Aug 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Shear wave elastography differentiates breast lesions]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/Shear-wave-elastography-differentiates-breast-lesions/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20August/082011_28_RSSembed.jpg"/><br />Ultrasound (US) elastography is a tool that reflects the hardness of a lesion, and a recent study using the currently available US technology has shown that elastography has nearly the same diagnostic performance as conventional US, with 86.5% (45 of 52) sensitivity, 89.8%...<br/>Article by: Breast Cancer Research and Treatment 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 21 Aug 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Which techniques for colorectal cancer screening in colitis patients?]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/Which-techniques-for-colorectal-cancer-screening-in-colitis-patients/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20August/082011_21_RSSembed.jpg"/><br />Patients with ulcerative colitis (UC) and Crohn's disease affecting colon (CDC) have an increased risk of developing colorectal cancer (CRC) [1]. First reports of association between UC and CRC were published in the 1920s and suggested a high incidence of CRC in inflammatory bowel disease (IBD) [2–4]....]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 21 Aug 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Case study: laparoscopy-assisted distal gastrectomy]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/Case-study-laparoscopy-assisted-distal-gastrectomy/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20August/082011_21_RSSembed.jpg"/><br /><p>&nbsp;Laparoscopic gastrectomy with lymph node dissection, such as laparoscopy-assisted distal gastrectomy (LADG), has been widely accepted as the treatment for early gastric cancer with the risk of lymph node metastasis, especially in Asia since 1991.</p><br/>Article by: Annals of surgical oncology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 21 Aug 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Review: cross-sectional abdominal imaging in oncology]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/Review-cross-sectional-abdominal-imaging-in-oncology/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20August/082011_24_RSSembed.jpg"/><br />Cross-sectional imaging of acute abdominal pain is a complex endeavor due to the multiple organ systems in the abdomen and pelvis and the broad differential diagnoses to be considered. While the imaging findings of many common, acute entities have been well described, an...<br/>Article by: Emergency Radiology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 14 Aug 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[DW-MRI aids bladder cancer diagnosis]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/DW-MRI-aids-bladder-cancer-diagnosis/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20August/082011_27_RSSembed.jpg"/><br />Histological grade and tumour (T) stage are of prognostic importance in bladder cancer. In non-muscle-invasive bladder cancer (NMIBC, stage T1 or less), both histological grade and T stage are associated with disease recurrence and progression [1]. Cancer-specific survival (CSS) for patients...<br/>Article by: European Radiology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 14 Aug 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Positive FDG-PET: lung cancer or pulmonary aspergillosis?]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/Positive-FDG-PET-lung-cancer-or-pulmonary-aspergillosis/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20August/082011_30_RSSembed.jpg"/><br />Lung cancer remains the leading cause of cancer-related deaths for both men and women in the UK. Early diagnosis and treatment can improve morbidity and mortality. The of positive emission tomography (PET) has led to improved diagnosis, staging and treatment evaluation for lung cancer. PET sensitivity...<br/>Article by: Thorax 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 14 Aug 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Improving diagnostic imaging of prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/Improving-diagnostic-imaging-of-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20August/082011_26_RSSembed.jpg"/><br />According to the current guidelines, 10-12 random biopsies are to be taken in case of suspected cancer. However, multiple systematic biopsies often fail to identify prostate cancer even in patients with high PSA values [1-4]. In case of negative prostate biopsies, many patients are offered...<br/>Article by: World Journal of Urology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 31 Jul 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Multi-parametric MRI identifies clinically important prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/Multi-parametric-MRI-identifies-clinically-important-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20August/082011_29_RSSembed.jpg"/><br />Overdiagnosis is arguably the greatest challenge in the management of men with prostate cancer. Multi-parametric (mp)-MRI prior to prostate biopsy may have a role in ruling-in and ruling-out clinically significant disease. Patients and Methods 114 consecutive men at risk of prostate cancer with previous...<br/>Article by: Urologia Internationalis 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 31 Jul 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Variability in CT lung tumor measurements on immediate re-imaging]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/Variability-in-CT-lung-tumor-measurements-on-immediate-re-imaging/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20August/082011_22_RSSembed.jpg"/><br />Purpose We use changes in tumor measurements to assess response and progression, both in routine care and as the primary of clinical trials. However, the variability of computed tomography (CT) –based tumor measurement has not been comprehensively ...<br/>Article by: JCO 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 31 Jul 2011 23:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[PET/CT for the management of solid tumors]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Aug/PETCT-for-the-management-of-solid-tumors/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13313/150.jpg"/><br />PET/CT is establishing itself as an invaluable tool in the staging and management of an increasing range of solid tumors. A recent report has demonstrated the high sensitivity and specificity of the combined imaging modality in the identification of distant metastases in patients with primary breast cancer.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 31 Aug 2011 16:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Imaging-related issues in HCC]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jul/Imaging-related-issues-in-HCC/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13278/150.jpg"/><br /><p>A round-up of recently published studies on how imaging techniques can contribute to the management of hepatocellular carcinoma.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 01 Jul 2011 20:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Surgery and radiotherapy for extrapulmonary small cell carcinoma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jul/Surgery-and-radiotherapy-for-extrapulmonary-small-cell-carcinoma/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20july/072011_21_RSSembed.jpg"/><br /><b>Background and Objectives </b>Extrapulmonary small cell carcinomas (EPSCC) are rare tumors where therapy remains poorly defined. We sought to determine the impact of surgical extirpation and radiation therapy for outcomes of EPSCC.<br/>Article by: Journal of Surgical Oncology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 01 Jul 2011 06:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Radiotherapy aids survival in adrenal metastasis from lung cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jul/Radiotherapy-aids-survival-in-adrenal-metastasis-from-lung-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20july/072011_24_RSSembed.jpg"/><br /><b>Introduction</b> Several studies have reported improved survival after adrenalectomy in patients with adrenal metastases from lung cancer. In this study, we evaluated the clinical results of radiotherapy performed for local control in patients with this disease.<br />]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 01 Jul 2011 06:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[5-year outcomes of HIFU treatment in localized prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jul/5-year-outcomes-of-HIFU-treatment-in-localized-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20july/072011_26_RSSembed.jpg"/><br />To determine oncological outcomes after high‐intensity focused ultrasonography (HIFU) treatment in patients with localized prostate cancer using a new, more accurate, definition (‘Stuttgart’ definition) of biochemical failure.<br />]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 01 Jul 2011 06:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Implementing guidance to optimize neuro-oncology services]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jul/Implementing-guidance-to-optimize-neuro-oncology-services/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20july/072011_29_RSSembed.jpg"/><br /><b>Background </b>Brain tumours account for &lt;2% of all primary neoplasms but are responsible for 7% of the years of life lost from cancer before age 70 years. The latest survival trends for patients with CNS malignancies have remained largely static. The objective of this study was to evaluate the change in practice as a result of implementing the Improving Outcomes Guidance from the UK National Institute for Health and Clinical Excellence (NICE).<br />]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 01 Jul 2011 06:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[MRI predicts recurrence risk after surgery in low rectal cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jul/MRI-predicts-recurrence-risk-after-surgery-in-low-rectal-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20july/072011_28_RSSembed.jpg"/><br /><b>Background</b> &nbsp;&nbsp;Low rectal cancers have poor outcomes. It has been suggested that low tumours are biologically more aggressive and tend to be more locally advanced at presentation. Pre-operative identification of prognostic factors will enable use of selective neoadjuvant therapies and possibly increase sphincter-sparing rates where oncologically safe. <br /><br/>Article by: Annals of surgical oncology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 01 Jul 2011 06:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[F-18 FDG PET/CT differentiates malignant and benign pleural disease in NSCLC]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jul/F-18-FDG-PETCT-differentiates-malignant-and-benign-pleural-disease-in-NSCLC/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20july/072011_25_RSSembed.jpg"/><br /><b>Background </b>The purpose of this study was to evaluate the accuracy of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) imaging in the detection of malignant pleural effusion and pleural metastasis in patients with non-small cell lung cancer (NSCLC). <br />]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 01 Jul 2011 06:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Innovations in anticancer drug delivery]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jun/Innovations-in-anticancer-drug-delivery/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/13180/article1_150.jpg"/><br />We present a round-up of the latest published studies of microbubble and nanocarrier delivery systems, and discuss the implications for cancer management.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 02 Jun 2011 19:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Safety of radioiodine therapy for thyroid cancer assessed]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jun/Safety-of-radioiodine-therapy-for-thyroid-cancer-assessed/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20June/062011_23_RSSembed.jpg"/><br /><strong>Purposes</strong> To evaluate the dosimetric effect of outpatient radioiodine therapy for thyroid cancer in members of a patient's family and their living environment, when using iodine-131 doses reaching 7.4 GBq. The following parameters were thus defined: (a) whole-body radiation doses to caregivers, (b) the production of contaminated solid waste, and (c) radiation potential and surface contamination within patients' living quarters.<br /><br/>Article by: Clinical Nuclear Medicine 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Jun 2011 10:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Study: CT-guided microwave ablation of adrenal tumors]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jun/Study-CT-guided-microwave-ablation-of-adrenal-tumors/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20June/062011_25_RSSembed.jpg"/><br /><strong>Background </strong>Microwave ablation has recently been developed as a safe and effective treatment for a variety of tumors. The authors evaluated the safety and efficacy of computed tomography (CT)-guided percutaneous microwave ablation of adrenal malignant tumors.<br /><br/>Article by: Cancer 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Jun 2011 10:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Case series: extracolonic findings on CT colonography]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jun/Case-series-extracolonic-findings-on-CT-colonography/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20June/062011_30_RSSembed.jpg"/><br /><strong>Introduction</strong> Computed tomographic colonography (CTC) is a non‐invasive method of examining the colon and is used for colorectal polyp and mass diagnosis. As the entire abdomen is examined, incidental extracolonic pathologies can be diagnosed. The types of extracolonic findings (ECFs) and their frequency have not been explored in an Australian setting.<br /><br/>Article by: Australasian Radiology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Jun 2011 10:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Mammography screen sensitivity lower after previous breast surgery]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jun/Mammography-screen-sensitivity-lower-after-previous-breast-surgery/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20June/062011_21_RSSembed.jpg"/><br />Few data are available on the effect of previous benign breast surgery on screening mammography accuracy. We determined whether sensitivity of screening mammography and tumor characteristics are different for women with and without previous benign breast surgery. We included a consecutive series of 317,398 screening mammograms of women screened between 1997 and 2008. During 2-year follow-up, clinical data, breast imaging, biopsy and surgery reports were collected from women with screen-detected or interval breast cancers. Screening sensitivity, tumor biology and tumor stages were compared between 168 women with breast cancer and prior ipsilateral benign breast surgery and 2,039 women with breast cancer but without previous ipsilateral, benign breast surgery. The sensitivity of screening mammography was significantly lower for women with prior surgery [64.3% (108/168) <i>versus</i> 73.4% (1,496/2,039), <i>p</i> = 0.01]. The concomitant increased interval cancer risk remained significant after logistic regression adjustment for age and breast density (OR = 1.5, 95% CI: 1.1–2.1). Comparing screen-detected cancers in women with and without prior breast surgery, no significant differences in estrogen receptor status (<i>p</i> = 0.56), mitotic activity (<i>p</i> = 0.17), proportions of large (T2+) tumors (<i>p</i> = 0.6) or lymph node positive tumors (<i>p</i> = 0.4) were found. Also for interval cancers, no differences were found in estrogen receptor status (<i>p</i> = 0.41), mitotic activity (<i>p</i> = 0.39), proportions of large tumors (<i>p</i> = 0.9) and lymph node positive tumors (<i>p</i> = 0.5) between women with and without prior breast surgery. We conclude that sensitivity of screening mammography is significantly lower in women with previous benign breast surgery than without, but tumor characteristics are comparable both for screen detected cancers and interval cancers.<br/>Article by: International Journal of Cancer 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Jun 2011 10:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Age and preoperative MRI in women with breast cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jun/Age-and-preoperative-MRI-in-women-with-breast-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20June/062011_24_RSSembed.jpg"/><br /><strong>Background</strong> &nbsp;&nbsp;The influence of patient age on multidisciplinary treatment planning after preoperative breast magnetic resonance imaging (MRI) and its influence on the surgical decision-making process are unclear. <br /><br/>Article by: Annals of surgical oncology 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Jun 2011 10:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Primary Tumor Volume Measured by FDG PET and CT in Nasopharyngeal Carcinoma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jun/Primary-Tumor-Volume-Measured-by-FDG-PET-and-CT-in-Nasopharyngeal-Carcinoma/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20June%20v2/062011_14_RSSembed.jpg"/><br /><strong>Background</strong> The prognostic value of CT-derived primary tumor volume in patients with nasopharyngeal carcinoma (NPC) has been demonstrated in our previous serial studies. The purpose of the present study is to compare the primary tumor volume measured by FDG PET and traditional CT in NPC, and to ascertain their prognostic value.<br/>Article by: Clinical Nuclear Medicine 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Jun 2011 10:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[CT-based simulation linked to higher survival in radiotherapy-treated NSCLC]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jun/CT-based-simulation-linked-to-higher-survival-in-radiotherapy-treated-NSCLC/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20June/062011_22_RSSembed.jpg"/><br /><strong>Purpose</strong> Technical studies suggest that computed tomography (CT) –based simulation improves the therapeutic ratio for thoracic radiation therapy (TRT), although few studies have evaluated its use or impact on outcomes. <br /><br/>Article by: JCO 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Jun 2011 10:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Can FDG-PET predict radiotherapy outcomes in head and neck cancer?]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/May/Can-FDG-PET-predict-radiotherapy-outcomes-in-head-and-neck-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20May/052011_21_RSSembed.jpg"/><br />Purpose: In head and neck cancer (HNC) various treatment strategies have been developed to improve outcome, but selecting patients for these intensified treatments remains difficult. Therefore, identification of novel pretreatment assays to predict outcome is of interest. In HNC there are indications that pretreatment tumour <sup>18</sup>F-fluorodeoxyglucose (FDG) uptake may be an independent prognostic factor. The aim of this study was to assess the prognostic value of FDG uptake and CT-based and FDG PET-based primary tumour volume measurements in patients with HNC treated with (chemo)radiotherapy. <br /><br/>Article by: European Journal of Nuclear Medicine 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 01 May 2011 16:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Near-infrared fluorescence imaging evaluated in colon cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/May/Near-infrared-fluorescence-imaging-evaluated-in-colon-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20May/052011_24_RSSembed.jpg"/><br />Background: Early and accurate detection of adenomatous colonic polyps is a major concern in the prevention of colon cancer. Near-infrared fluorescence (NIRF) imaging with optical probes targeting specific peptides enables the noninvasive visualization and characterization of lesions. Matrix metalloproteinases (MMPs) are known to play an important role in tumorigenesis and tumor progression. <br /><br/>Article by: Digestive Diseases and Sciences 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 01 May 2011 16:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Sonoelastography distinguishes benign and malignant pancreatic masses]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/May/Sonoelastography-distinguishes-benign-and-malignant-pancreatic-masses/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20May/052011_26_RSSembed.jpg"/><br />Sonoelastography is based on the knowledge that some diseases, such as cancer, lead to a change in tissue hardness. Elastography examines the elastic properties of tissues by applying a slight compression to the tissue and comparing the images obtained before and after this compression. Endoscopic ultrasonography (EUS) is today the best technique to diagnose a small pancreatic mass and to determine the histology of such lesions. However, the accuracy of EUS-FNA is around 85–90%. In this study, elastography was used to differentiate benign from malignant pancreatic masses. The bright future of the second generation of elastography, the quantitative elastography or ratio elastography, is also discussed.]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Sun, 01 May 2011 16:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Preserving fertility in cancer patients: two views]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/May/Preserving-fertility-in-cancer-patients-two-views/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12962/webAppMobile%26RSS.jpg"/><br />When and how should patients diagnosed with cancer be informed of the potential risk of infertility after cancer treatment? Two specialists provide insights into the issues faced in day-to-day practice.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 02 May 2011 20:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Audio interview: experiences with digital mammography]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/Audio-interview-experiences-with-digital-mammography/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12849/150r.jpg"/><br />A specialist discusses his unit’s experiences with full-field digital mammography and its role in breast cancer screening. 
<p>Listen to Dr Nick Perry of the London Breast Institute report on 11 years of experience with digital mammography in this audio interview conducted exclusively for GetInsideHealth on 23 March 2011.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 29 Mar 2011 16:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Optical techniques combined for skin cancer assessment]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Apr/Optical-techniques-combined-for-skin-cancer-assessment/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20April/042011_27_RSSembed.jpg"/><br /><p><strong>Background and Objective </strong>The current standard for diagnosis of skin cancers is visual inspection followed by biopsy and histopathology. This process can be invasive, subjective, time consuming, and costly. Optical techniques, including Optical Coherence Tomography (OCT) and Raman Spectroscopy (RS), have been developed to perform non-invasive characterization of skin lesions based on either morphological or biochemical features of disease. The objective of this work is to report a clinical instrument capable of both morphological and biochemical characterization of skin cancers with RS-OCT.<br /></p><br/>Article by: Lasers in Surgery and Medicine 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 26 Apr 2011 10:47:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[PET probe useful for evaluating prostate cancer metastasis?]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Apr/PET-probe-useful-for-evaluating-prostate-cancer-metastasis/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20April/042011_30_RSSembed.jpg"/><br /><p><strong>Purpose</strong> &nbsp;&nbsp;The ability of PET to aid in the diagnosis and management of recurrent and/or disseminated metastatic prostate cancer may be enhanced by the development of novel prognostic imaging probes. Accumulating experimental evidence indicates that overexpression of integrin α<sub>2</sub>β<sub>1</sub> may correlate with progression in human prostate cancer. In this study, <sup>64</sup>Cu-labeled integrin α<sub>2</sub>β<sub>1</sub>-targeted PET probes were designed and evaluated for the imaging of prostate cancer. <br /></p><br/>Article by: European Journal of Nuclear Medicine 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 26 Apr 2011 10:47:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Hyperpolarized urea imaging useful in preclinical cancer models]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Apr/Hyperpolarized-urea-imaging-useful-in-preclinical-cancer-models/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20April/042011_28_RSSembed.jpg"/><br /><p><strong>Abstract</strong></p>
<p><strong>Purpose </strong>To demonstrate dynamic imaging of a diffusible perfusion tracer, hyperpolarized [<sup>13</sup>C]urea, for regional measurement of blood flow in preclinical cancer models.<br /></p><br/>Article by: Journal of Magnetic Resonance Imaging 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 26 Apr 2011 10:47:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[When is MRI useful in cervical cancer management?]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Apr/When-is-MRI-useful-in-cervical-cancer-management/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20April/042011_25_RSSembed.jpg"/><br /><p><strong>Abstarct</strong></p>
<p><strong>Background</strong> Cervical carcinoma is the only gynecological tumor still being staged mainly by clinical examination and only a limited use of diagnostic radiology. Cross sectional imaging is increasingly used as an aid in the staging procedure. We wanted to assess the impact of magnetic resonance imaging (MRI) in addition to the clinical staging of patients with carcinoma of the uterine cervix. <br /></p><br/>Article by: Acta Oncologica 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 26 Apr 2011 10:47:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[How device-assisted enteroscopy aids small bowel cancer diagnosis]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Apr/How-device-assisted-enteroscopy-aids-small-bowel-cancer-diagnosis/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20April/042011_22_RSSembed.jpg"/><br /><p><strong>Abstarct</strong></p>
<p><strong>Background</strong> &nbsp;&nbsp;Primary malignant neoplasms of the small bowel comprise only 1-3% of all gastrointestinal malignancies. Small bowel cancers pose a significant diagnostic challenge. The recent development of video capsule endoscopy (VCE) and device-assisted enteroscopy (DAE) have greatly facilitated evaluation of the small bowel. <br /></p><br/>Article by: Digestive Diseases and Sciences 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 26 Apr 2011 10:47:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[How IMRT techniques affect xerostomia and quality of life in nasopharyngeal cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Apr/How-IMRT-techniques-affect-xerostomia-and-quality-of-life-in-nasopharyngeal-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20April/042011_24_RSSembed.jpg"/><br /><p><strong>Abstract</strong></p>
<p><strong>Background </strong>The purpose of this study was to compare 5-field and 7-field intensity-modulated radiation therapy (IMRT) techniques in terms of xerostomia and related quality of life in patients with nasopharyngeal cancer.<br /></p>]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 26 Apr 2011 10:47:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[MRI reveals extent of tumor necrosis]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Apr/MRI-reveals-extent-of-tumor-necrosis/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20April/042011_21_RSSembed.jpg"/><br /><p><strong>Abstract</strong></p>
<p><strong>Background</strong> The prognostic and predictive value of magnetic resonance (MR) investigations in clinical oncology may be improved by implementing strategies for discriminating between viable and necrotic tissue in tumors. The purpose of this preclinical study was to investigate whether the extent of necrosis in tumors can be assessed by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and/or <i>T</i><sub>2</sub>-weighted MR imaging. <br /></p><br/>Article by: Acta Oncologica 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 26 Apr 2011 10:47:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Appropriate use of imaging in prostate cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Apr/Appropriate-use-of-imaging-in-prostate-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM%20April/042011_23_RSSembed.jpg"/><br /><p>Over one-third of patients with low-risk prostate cancer patients are getting radiographic imaging scans that are not recommended by treatment guidelines, while nearly 40% of high-risk patients who should be receiving the tests aren't getting them, according to a study of 30,183 patients reported here at the Genitourinary Cancers Symposium.<!--<GNMSETMEDIAPOPUP>--></p><br/>Article by: Oncology Times 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 26 Apr 2011 10:47:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[The ongoing revolution in colorectal cancer screening]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/The-ongoing-revolution-in-colorectal-cancer-screening/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12838/150.jpg"/><br /><p>Is "a small revolution in screening for colon cancer" underway, as some specialists recently concluded? To mark National Colorectal Cancer Awareness Month in the USA, we look at the latest published clinical data on colorectal cancer screening.</p>
<p>In a review paper published at the end of 2010, specialists from the Unit Of Medical Oncology at the Ospedali Riuniti di Bergamo, Italy, wrote that "a small revolution in screening for colon cancer is in the making".</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 18 Mar 2011 21:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Audio interview: spotlight on MRgFUS]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/Audio-interview-spotlight-on-MRgFUS/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12820/150d.jpg"/><br />What are the present and future applications of MR-guided focused ultrasound? 
<p>In this audio interview conducted exclusively for GetInsideHealth on 23 February 2011, Dr William G Bradley, Jr, discusses how MR-guided focused ultrasound (MRgFUS) is currently being used in clinical practice, and provides insights into likely future uses of the technique based on the findings of cutting-edge research.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 07 Mar 2011 20:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Radiotherapy for DCIS: when and how]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/Radiotherapy-for-DCIS-when-and-how/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12818/150c.jpg"/><br />What have newly published papers added to our understanding of the management of ductal carcinoma in situ, including the role of radiotherapy? 
<p>In recent months several important new papers have been published relating to the diagnosis and management of ductal carcinoma in situ (DCIS) – the pathology that accounts for about one in five of all screen-detected breast cancers. Here we present a round-up of some of the main findings and the implications for clinical practice and future research.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 07 Mar 2011 19:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Insights from the National Lung Screening Trial]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Feb/Insights-from-the-National-Lung-Screening-Trial/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/NL/Articles/lung150.jpg"/><br /><p>Should low-dose helical CT now be the method of choice for lung cancer screening? In November 2010 the USA’s National Cancer Institute (NCI) released early findings from the National Lung Screening Trial (NLST) showing that screening with low-dose helical CT was associated with a significant mortality benefit compared with chest X-ray screening, in older current and former heavy smokers. Overall, there were 20% fewer lung cancer deaths in the population screened using CT than in the population screened using X-ray.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 28 Feb 2011 15:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Assessing and addressing quality of life]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Feb/Assessing-and-addressing-quality-of-life/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12508/150.jpg"/><br /><p>The importance of considering quality of life in women with gynecologic cancer.</p>
<p>Recent developments have highlighted the continuing and growing importance of considering quality of life (QoL) in women with cancer, and gynaecologic cancer in particular.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Mon, 28 Feb 2011 15:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Acetate PET useful for assessing response of prostate cancer bone metastases]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/Acetate-PET-useful-for-assessing-response-of-prostate-cancer-bone-metastases/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM_March/032011_23_RSSembed.jpg"/><br /><p><strong>Abstract </strong></p>
<p><strong>Purpose of the Report</strong> This study tested the feasibility of C11-acetate (acetate) positron emission tomography (PET) imaging to assess response to therapy in men with bone metastatic prostate cancer and compared results for disease detection and response evaluation with F-18 fluorodeoxyglucose (FDG) PET.<br /></p><br/>Article by: Clinical Nuclear Medicine 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 31 Mar 2011 11:03:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Review: image-guided surgery in head and neck cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/Review-image-guided-surgery-in-head-and-neck-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM_March/032011_27_webAppMobile%26RSS.jpg"/><br /><p><strong>Abstract</strong> </p>
<p>A key aspect for the postoperative prognosis of patients with head and neck cancer is complete tumor resection. In current practice, the intraoperative assessment of the tumor-free margin is dependent on visual appearance and palpation of the tumor. Optical imaging has the potential of traversing the gap between radiology and surgery by providing real-time visualization of the tumor, thereby allowing for image-guided surgery. The use of the near-infrared light spectrum offers 2 essential advantages: increased tissue penetration of light and an increased signal-to-background ratio of contrast agents.</p>]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 31 Mar 2011 11:03:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Optimizing radiotherapy for tongue cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/Optimizing-radiotherapy-for-tongue-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM_March/032011_28_webAppMobile%26RSS.jpg"/><br /><p><strong>Abstract </strong></p>
<p><strong>Background </strong>No universal consensus of optimal radiation target coverage for oral tongue cancer exists, and there is wide variability in practice. Some centers use intensity-modulated radiotherapy (IMRT) to selectively target only certain regions at risk while sparing others; however, patterns of failure after such selective targeting are rarely reported.<br /></p>]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 31 Mar 2011 11:03:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[The impact of symptom interference using the MD Anderson Symptom Inventory&#8208;Brain Tumor Module (MDASI&#8208;BT) on prediction of recurrence in primary brain tumor patients]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/The-impact-of-symptom-interference-using-the-MD-Anderson-Symptom-Inventory8208Brain-Tumor-Module-MDASI8208BT-on-prediction-of-recurrence-in-primary-brain-tumor-patients/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM_March/032011_29_webAppMobile%26RSS.jpg"/><br /><p><strong>Abstract </strong></p>
<p><strong>Background </strong>Tumor grade, age, extent of resection, and performance status are established prognostic factors for survival in primary brain tumor (PBT) patients. Development of disease-related symptoms is predictive of tumor recurrence in other cancers but has not been reported in the PBT population.<br /></p><br/>Article by: Cancer 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 31 Mar 2011 11:03:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[PET/CT for assessing bone involvement in prostate and breast cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/PETCT-for-assessing-bone-involvement-in-prostate-and-breast-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM_March/032011_26_webAppMobile%26RSS.jpg"/><br /><p><strong>Abstract </strong></p>
<p><strong>Objective</strong> To evaluate the accuracy of <sup>18</sup>F-fluoride PET/computed tomography (CT) to detect bone metastases (BMs) in a breast and prostate cancer population, using magnetic resonance imaging (MRI) or thin-slice CT as a gold standard.<br /></p><br/>Article by: Nuclear Medicine Communications 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 31 Mar 2011 11:03:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[MRI vs MSCT for preop assessment of colorectal liver metastases]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/MRI-vs-MSCT-for-preop-assessment-of-colorectal-liver-metastases/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM_March/032011_24_webAppMobile%26RSS.jpg"/><br /><p><strong>Abstract </strong></p>
<p><strong>Introduction</strong> To determine the best imaging modality for preoperative detection, characterization and measurement of colorectal liver metastases (CRLM) after neoadjuvant chemotherapy (NAC). <br /></p><br/>Article by: Digestive Surgery 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 31 Mar 2011 11:03:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Correlating DCE MRI with FDG-PET/CT in rectal cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Mar/Correlating-DCE-MRI-with-FDG-PETCT-in-rectal-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/Global/GNM_March/032011_25_webAppMobile%26RSS.jpg"/><br /><p><strong>Abstract </strong></p>
<p><strong>Purpose </strong>To assess the correlations between parameters measured on dynamic contrast-enhanced magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) in rectal cancer.<br /></p><br/>Article by: Journal of Magnetic Resonance Imaging 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 31 Mar 2011 11:03:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[FLT- and FDG-PET in gastroenteropancreatic endocrine tumors]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jan/FLT--and-FDG-PET-in-gastroenteropancreatic-endocrine-tumors/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12528/Gas08_150.jpg"/><br /><b>Abstract</b> 
<p><b>Purpose</b> Gastro-entero-pancreatic (GEP) endocrine tumours are a heterogenous group of tumours of variable localization and prognosis. It has been suggested that positron emission tomography (PET) using 2-[<sup>18</sup>F]fluoro-2-deoxy-D-glucose (<sup>18</sup>F-FDG) may have a prognostic value and help to identify patients at risk of progression. [<sup>18</sup>F]fluoro-3′-deoxy-3′-L-fluorothymidine (<sup>18</sup>F-FLT) has been recently developed as a PET proliferation tracer. At present, there are no studies investigating its role in GEP. The aim of this prospective study was to assess the value of <sup>18</sup>F-FLT-PET for the evaluation of GEP.</p><br/>Article by: Nuclear Medicine Communications 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 27 Jan 2011 11:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[MRI findings and prognosis in invasive ductal carcinoma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jan/MRI-findings-and-prognosis-in-invasive-ductal-carcinoma/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12529/Onc03_150.jpg"/><br /><b>Abstract</b> 
<p><b>Purpose </b>To evaluate the correlation of the mean and minimal apparent diffusion coefficient values (ADC<sub>mean</sub>, ADC<sub>minimal</sub>) and dynamic magnetic resonance imaging (MRI) findings with prognostic factors in invasive ductal carcinoma.</p><br/>Article by: Journal of Magnetic Resonance Imaging 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 27 Jan 2011 11:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[PET/CT evaluated in pre-op staging of lung cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jan/PETCT-evaluated-in-pre-op-staging-of-lung-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12531/Onc09_150.jpg"/><br /><b>Abstract</b> 
<p><b>Purpose</b> &nbsp;&nbsp;Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.</p><br/>Article by: European Journal of Nuclear Medicine 2011]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 27 Jan 2011 11:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[PET/CT for staging and follow up of patients with malignancies]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Dec/The-introduction-of-combined-PETCT-scanners-has-provided-oncologists-with-a-powerful-non-invasive-tool/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12428/150.jpg"/><br />Since positron emission tomography (PET) was introduced in the 1970s, it has evolved into a powerful and non-invasive three-dimensional imaging technique, now primarily used in oncology. In oncology, PET usually makes use of a radio-labelled glucose analog, fluorodeoxyglucose F18 (FDG), and has a number of applications including tumor detection, staging, and prognostic stratification, evaluation of a patient’s response to therapy, detection of recurrences and restaging, and the precise planning of radiation treatment.<sup>1</sup> 
<p>Although PET was found to be useful for the functional visualisation of anatomical structures, the accurate localization of structures remained problematic, due to patient movement, and particularly when dealing with the more flexible parts of the body which are prone to involuntary movement. Initially, PET images were aligned with computed tomography (CT) images using sophisticated software, but a major advance in accuracy was achieved with the introduction of combined modality PET/CT scanners.<sup>2</sup>&nbsp;</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 21 Dec 2010 15:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Pilot study shows benefits of near-infra red sentinel lymph node mapping]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2011/Jan/Pilot-study-shows-benefits-of-near-infra-red-sentinel-lymph-node-mapping/]]></link>
                <description>
                <![CDATA[<p><strong>Abstract </strong></p>
<p><strong>Background</strong> &nbsp;&nbsp;Sentinel lymph node (SLN) mapping in colorectal cancer may have prognostic and therapeutic significance; however, currently available techniques are not optimal. We hypothesized that the combination of invisible near-infrared (NIR) fluorescent light and ex vivo injection could solve remaining problems of SLN mapping in colorectal cancer. <br /></p><br/>Article by: Annals of surgical oncology 2010]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 28 Jan 2011 11:02:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010:  First study of automated 3D ultrasound shows promise for breast cancer screening]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Dec/RSNA-2010--First-study-of-automated-3D-ultrasound-shows-promise-for-breast-cancer-screening/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12401/gen_mobile1.jpg"/><br />The first large scale study of the accuracy of automated 3D ultrasound (US) imaging in breast cancer screening was presented at the 2010 RSNA meeting. Results suggested that this modality is as accurate as conventional mammography. The potential advantages of 3D US is a more complete “bird’s eye” view of pathology, including a better appreciation of volume when abnormalities are found. The potential advantage of automation is a reduction in physician time and, therefore, cost. 
<p>In this study, 304 patients undergoing screening mammography also underwent automated 3D US examination. The conventional mammography images were assessed by one independent examiner and the 3D images were assessed by two additional independent examiners. Conventional mammography was employed as the reference standard in order to calculate the sensitivity and specificity of the automated 3D technique.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 02 Dec 2010 01:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Annual mammography in women aged 40-50 lowers mastectomy rate following breast cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Dec/RSNA-2010-Annual-mammography-in-women-aged-40-50-lowers-mastectomy-rate-following-breast-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12375/mobile1.jpg"/><br />Regular screening for breast cancer using mammography in women between the ages of 40 and 50 allows greater likelihood of conservative surgery for breast cancer, as opposed to mastectomy, according to new research presented at RSNA 2010 on Thursday, December 2nd. 
<p>“This work is quite a novel approach in that success of screening is usually measured in terms of reduction in mortality from breast cancer,” said Nicholas Perry, MD, of The London Breast Institute, London, UK. “We are not aware of any other studies in this age group comparing success in terms of breast preservation,” he added.</p>
<p>In their study, Dr. Perry and colleagues compared mastectomy rates following breast cancer diagnosis at a UK center in women aged 40-50 with a prior mammogram within the previous year to those with longer interval or no previous mammography.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 02 Dec 2010 20:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Significant reductions in exposure possible during multi-phasic CT examinations of the liver]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Dec/RSNA-2010-Significant-reductions-in-exposure-possible-during-multi-phasic-CT-examinations-of-the-liver/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12373/gen_mobile1.jpg"/><br />A study presented at this year’s RSNA conference on December 2nd shows that it is possible to achieve significant reductions in radiation exposure--without a loss in sensitivity--during multi-phasic computed tomography (CT) examinations of the liver. 
<p>Multi-phasic CT examinations of the liver can be used to detect malignant liver lesions; however, they can deliver doses of radiation that may increase a patient’s lifetime cancer risk. </p>
<p>To investigate whether it is possible to reduce the level of exposure while maintaining diagnostic accuracy, specialists at Royal Brisbane &amp; Women's Hospital, Moorooka, Australia, performed a study using a CT liver lesion phantom consisting of a soft-tissue-equivalent disk with spherical lesions (9.5mm and 4.8mm diameter, each with a density 10 HU below background).</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 02 Dec 2010 23:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Thin-section chest CT can help identify transient vs. persistent part-solid nodules in individuals at high risk for lung cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Dec/RSNA-2010-Thin-section-chest-CT-can-help-identify-transient-vs-persistent-part-solid-nodules-in-individuals-at-high-risk-for-lung-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12369/mobile1.jpg"/><br />According to results of a new study presented at RSNA 2010 on 1 December, it is possible to discriminate accurately between transient and persistent part-solid nodules (PSNs) with the help of thin-section CT imaging--in conjunction with clinical data--in individuals at high risk for lung cancer. 
<p>Specialists at the Department of Radiology, Seoul National University Hospital, Seoul, Korea, have been able to identify key lesion characteristics revealed by CT examination that can enable clinicians to predict very accurately whether PSNs would be transient or persistent on follow-up CTs.</p>
<p>“Part-solid nodules have been reported to indicate a high probability of early lung cancer in many previous studies,” said Yong Sub Song, MD, who presented the research. “However, we observed that a substantial proportion of PSNs detected at screening CT could be transient because of inflammation or hemorrhage,” Dr. Song noted.<br /></p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Dec 2010 18:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: FDG-PET/CT useful in early detection, staging, and treatment of PTLD after solid organ transplantation.]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Dec/RSNA-2010-FDG-PETCT-useful-in-early-detection-staging-and-treatment-of-PTLD-after-solid-organ-transplantation/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12367/gen_mobile1.jpg"/><br />Results of a new study presented at this year’s RSNA congress on 1 December suggest that combining fluorodeoxyglucose positron emission tomography (FDG-PET) scanning with computed tomography (CT) can help in the early detection, staging, and treatment of post-transplant lymphoproliferative disease (PTLD) after solid organ transplantation.&nbsp; 
<p>“PTLD is a rare, but serious and potentially lethal complication of solid organ transplantation,” said Homeira Zahiri, MD, University of Nebraska Medical Center, Omaha, Nebraska, who presented the study. “FDG-PET has proven useful for staging high and intermediate-grade lymphoma. However, the accuracy of FDG-PET for staging PTLD is unknown,” she added.</p>
<p>To investigate the usefulness of FDG-PET in the early detection, staging, and treatment of PTLD after solid organ transplantation, Dr. Zahiri’s team performed a study involving 16 transplant recipients with histologically confirmed PTLD.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Dec 2010 18:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Single-session radiofrequency ablation sufficient for most patients with benign thyroid nodules]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Dec/RSNA-2010-Single-session-radiofrequency-ablation-sufficient-for-most-patients-with-benign-thyroid-nodules/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12358/mobile1.jpg"/><br />A study presented at this year’s RSNA conference on 1 December has found that a single treatment session of radiofrequency ablation (RFA) is sufficient for most patients with benign thyroid nodules (BTN). 
<p>“RFA is a safe and effective nonsurgical treatment for symptomatic benign thyroid nodules,” said Jung-Yin Huh, MD, Gangnam CHA General Hospital, Seoul, Korea, who presented the results.</p>
<p>Dr. Huh’s team evaluated the efficacy of single- vs. dual-session RFA treatment in patients with BTN in a prospective randomized trial. 30 outpatients were randomly assigned to one session of RFA (RFA-1, n=15) or two sessions of RFA (RFA-2, n=15) and were subsequently followed for a period of at least 6 months.</p>
<p>RFA was performed under continuous ultrasound- (US) guidance with an 18-gauge internally cooled electrode. Dependent variables included nodule volume, cosmetic score and symptom score.<br /></p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Dec 2010 04:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Diffusion-weighted imaging outperforms conventional MRI in predicting response to chemoradiation in patients with locally advanced rectal cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Dec/RSNA-2010-Diffusion-weighted-imaging-outperforms-conventional-MRI-in-predicting-response-to-chemoradiation-in-patients-with-locally-advanced-rectal-cancer/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12352/mobile1.jpg"/><br />Specialists at G. d'Annunzio University in Chiety, Italy, have developed a method that can enable clinicians to better predict the outcome of chemoradiation treatment (CRT) in patients with locally advanced rectal cancer (LARC). The researchers described the new method in a Poster presentation on December 1st, 2010, at the Annual Meeting of the Radiological Society of North America (RSNA). 
<p>Lead investigator Antonella Filippone, MD, and colleagues used diffusion-weighted imaging (DWI) to assess response to CRT in patients with LARC. A total of 28 patients underwent magnetic resonance imaging (MRI) prior to and 8 weeks after treatment, including T2-weighted and an echo-planar DWI-sequence with 6 b-values (0 to 1000 mm2/sec), from which the apparent diffusion coefficient (ADC) was calculated.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Dec 2010 03:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Risk of developing cancer from CT much lower than previously believed]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Dec/RSNA-2010-Risk-of-developing-cancer-from-CT-much-lower-than-previously-believed/]]></link>
                <description>
                <![CDATA[<IMG width="150" height="138" border="0" src="/PageFiles/12348/gen_mobile1.jpg"/><br />The risk of developing cancer from ionizing radiation generated by computed tomography (CT) equipment appears to be significantly lower than previously estimated, according to results of a retrospective cohort study presented on 1 December at this year’s Annual Meeting of the Radiological Society of North America (RSNA). 
<p>The study was conducted by researchers at Stanford University, Stanford, California, and involved a review of Medicare claims submitted between 1998 and 2005 for over 10 million people, focusing on the well-characterized patient group of older adults, who are most frequently imaged. The data were analyzed in two temporally differentiated cohorts: 1998-2001 (N = 5,267,230) and 2002-2005 (N = 5,555,345). </p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 01 Dec 2010 03:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Image-guided cryoablation effectively relieves pain in patients with metastatic disease involving bone]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Nov/RSNA-2010-Image-guided-cryoablation-effectively-relieves-pain-in-patients-with-metastatic-disease-involving-bone/]]></link>
                <description>
                <![CDATA[Image-guided percutaneous cryoablation therapy results in effective and durable pain relief in patients with metastatic bone disease, according to a prospective multicenter trial presented on 30 November at this year’s Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). 
<p>“Cryoablation uses cold to destroy tumor,” explained lead investigator Matthew Callstrom, MD, PhD, Mayo Clinic, Rochester, Minnesota. “The ice that is generated in the body is visible with CT imaging, so the tumor can be treated aggressively--completely in many cases--while avoiding critical normal structures,” Dr. Callstrom stressed.</p>
<p>The study by Dr. Callstrom and colleagues enrolled 62 adult patients with painful bone metastases who had either failed or were poor candidates for conventional radiation treatment or chemotherapy. All patients were treated with CT-guided cryoablation using one or more cryoprobes under general anesthesia or conscious sedation. Osteolytic metastases involving or abutting bone were treated.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 30 Nov 2010 02:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Volumetric modulated arc therapy lowers total body dose and decreases anesthesia requirements in pediatric patients with diffuse pontine gliomas]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Nov/RSNA-2010-Volumetric-modulated-arc-therapy-lowers-total-body-dose-and-decreases-anesthesia-requirements-in-pediatric-patients-with-diffuse-pontine-gliomas/]]></link>
                <description>
                <![CDATA[Specialists at the John Stoddard Cancer Center in Des Moines, Iowa, have developed a volumetric modulated arc therapy (VMAT) for pediatric diffuse pontine gliomas (DPG), which makes it possible to deliver highly conformal doses of radiation with lower anesthesia requirements and decreased body dose, compared with previously available methods. Details of the research were presented at the RSNA 2010 conference in Chicago, on Tuesday, November 30th. 
<p>Diffuse pontine gliomas have a very high mortality rate, with a median survival of less than one year, mainly due to local failure patterns within the irradiated field during standard radiation therapy, explained Arshin Sheybani, MD, who presented the study.&nbsp; One option for delivering a higher dose, while limiting toxicities, is intensity modulated radiation therapy (IMRT). However, IMRT is associated with high monitor units (MU) and longer treatment times (TT), Dr. Sheybani said.<br /></p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 30 Nov 2010 02:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Post-therapy FDG PET/CT predicts outcome in patients with head and neck squamous cell carcinoma]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Nov/RSNA-2010-Post-therapy-FDG-PETCT-predicts-outcome-in-patients-with-head-and-neck-squamous-cell-carcinoma/]]></link>
                <description>
                <![CDATA[Performing Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) following treatment for head and neck squamous cell carcinoma (HNSCC) can help predict the outcome of treatment, according to a study presented at this year’s meeting of the Radiological Society of North America (RSNA) on 30 November 2010. 
<p>Researchers from Boston University School of Medicine (BUSM) conducted a retrospective chart analysis of 55 patients (40 men and 15 women) who were treated for biopsy-proven HNSCC between August 2004 and March 2009 at BUSM. Study endpoints included disease-free and overall survival, and the results were analyzed using statistical methods such as Fisher’s Exact Test and Kaplan-Meier estimator analysis.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 30 Nov 2010 00:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010: Novel reporting system of unexpected radiologic findings well received by most referring clinicians]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Nov/RSNA-2010-Novel-reporting-system-of-unexpected-radiologic-findings-well-received-by-most-referring-clinicians/]]></link>
                <description>
                <![CDATA[A new reporting system aimed at ensuring that unexpected radiologic findings are effectively communicated to referring clinicians is well received by most clinicians, according to a study presented on 30 November 2010 at the Annual Meeting of the Radiological Society of North America (RSNA) in Chicago. 
<p>The new system, which has been developed and implemented by the radiology department at Darthmouth-Hitchcock Medical Center in Lebanon, New Hampshire, automatically alerts referring clinicians about unexpected findings (UFs), and the radiology department follows up with them. If a clinician does not respond to repeated notices, then a certified letter is mailed to the patient informing him or her of the UF.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 30 Nov 2010 00:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[The role of integrated imaging in oncology: PET/MRI]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Nov/The-role-of-integrated-imaging-in-oncology-PETMRI/]]></link>
                <description>
                <![CDATA[How hybrid imaging systems combining PET and MRI could help advance oncology care.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 30 Nov 2010 15:30:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Optimizing magnetic resonance imaging of the breast]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Nov/Optimizing-magnetic-resonance-imaging-of-the-breast/]]></link>
                <description>
                <![CDATA[A review of good practice in breast MRI, to mark National Breast Cancer Awareness Month in the USA (October 1-31)<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 18 Nov 2010 18:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[RSNA 2010]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Nov/RSNA-2010/]]></link>
                <description>
                <![CDATA[<p>Check this page from November 30 to December 2 for extensive and regularly updated coverage of RSNA 2010.</p><br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 30 Nov 2010 14:00:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Managing advanced medullary thyroid cancer]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Nov/Managing-advanced-medullary-thyroid-cancer1/]]></link>
                <description>
                <![CDATA[An overview of recent developments in the use of radiation therapy in patients with advanced disease, and how it can help improve local disease control in selected patients.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 03 Nov 2010 11:25:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Do EU countries need nationwide screening programs for colorectal cancer?]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Aug/Do-EU-countries-need-nationwide-screening-programs-for-colorectal-cancer/]]></link>
                <description>
                <![CDATA[There have been suggestions that the decline in colorectal cancer in the USA is related to widespread screening programs. In view of this, the question has been asked why so few European countries have screening programs in place.<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Wed, 25 Aug 2010 14:04:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Virtual colonoscopy in 2010]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/Jul/Virtual-colonoscopy-in-2010/]]></link>
                <description>
                <![CDATA[An overview of recent papers on the appropriate use of computed tomography colonography (CTC).<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Fri, 02 Jul 2010 11:40:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[The impact of imaging]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2010/May/The-impact-of-imaging/]]></link>
                <description>
                <![CDATA[How imaging technologies have helped clinicians improve cancer management<br/>Article by: Excerpta Medica]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Thu, 13 May 2010 13:26:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
            <item>
                <title><![CDATA[Benefits Seen in Postcancer Weight-Lifting]]></title>
                <link><![CDATA[http://www.getinsidehealth.com/en/Library/Articles/en/2009/Aug/TIME19-sept09-BC/]]></link>
                <description>
                <![CDATA[For as many as two-thirds of breast-cancer survivors, their lifesaving cancer treatment can lead to an incurable and painful condition known as lymphedema. The condition commonly affects patients whose lymph nodes were removed during surgery, causing often debilitating swelling in the hands and arms because of lymph fluid buildup.<br/>Article by: TIME]]>
                </description>
                <ArticleAuthor><![CDATA[GetInsideHealth]]></ArticleAuthor>
                <pubDate><![CDATA[Tue, 18 Aug 2009 11:08:00 GMT]]></pubDate>
                <articleform><![CDATA[GetInsideHealth]]></articleform>
                <category><![CDATA[GetInsideHealth]]></category>
            </item>
        
    </channel>
</rss>

